Our prospective study investigated the impact of baseline blood zinc levels on the humoral immune response and production of anti-S1 IgG and IgM antibodies following COVID-19 mRNA vaccination in a Japanese cohort. The gene discussed is CD40LG; the disease is COVID-19.